Wang MengYun M - OmicsDI

Show results for

Proteomics (2)
Metabolomics (1)

Organisms

Homo sapiens (1)
Pseudomonas aeruginosa PAO1 (1)

Repository

iProX (2)
MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2023 (2)
2024 (1)

CHEBI ID

CHEBI:10106 (1)
CHEBI:10117 (1)
CHEBI:10217 (1)
CHEBI:110179 (1)
CHEBI:111 (1)
CHEBI:113545 (1)
CHEBI:116314 (1)
CHEBI:12350 (1)
CHEBI:1296 (1)
CHEBI:12962 (1)
CHEBI:131342 (1)
CHEBI:132138 (1)
CHEBI:132150 (1)
CHEBI:132223 (1)
CHEBI:132230 (1)
CHEBI:132403 (1)
CHEBI:132477 (1)
CHEBI:132582 (1)
CHEBI:132793 (1)
CHEBI:132983 (1)
CHEBI:133596 (1)
CHEBI:133600 (1)
CHEBI:133662 (1)
CHEBI:134468 (1)
CHEBI:134689 (1)
CHEBI:134856 (1)
CHEBI:135051 (1)
CHEBI:135574 (1)
CHEBI:135611 (1)
CHEBI:135976 (1)

Metabolite Name

(+)-alpha-tocopherol (1)
(-)-perillyl alcohol (1)
(-)-quebrachitol (1)
(-)-riboflavin (1)
(.+/-.)-cromakalim (1)
(2r,3r,4s,5s,6r)-2-[1,7-bis(4-hydroxyphenyl)heptan-3-yloxy]-6-(hydroxymethyl)oxane-3,4,5-triol (1)
(2r,3s,4s,5r,6r)-5-[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-2-(hydroxymethyl)-6-(2-phenylethoxy)oxane-3,4-diol (1)
(2s,3r,5r,10r,13r,14s,17s)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2r,3r,5r)-2,3,6-trihydroxy-5,6-dimethylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-6-one (1)
(3r,7r,9s,10s,12s,13r,14s,17r)-17-((2r)-6,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthrene-3,7,12-triol (1)
(r)-butyrylcarnitine (1)
.delta.-dodecalactone (1)
1,2-di-(9z,12z,15z-octadecatrienoyl)-sn-glycero-3-phosphocholine (1)
1,2-diamino-2-methylpropane (1)
1,2-diarachidonoyl-sn-glycero-3-phosphocholine (1)
1,2-dihexadecanoyl-sn-glycerol (1)
1,2-dihydroxyheptadec-16-en-4-yl acetate (1)
1,2-dihydroxyheptadec-16-yn-4-yl acetate (1)
1,2-dilinoleoyl-sn-glycero-3-phosphoethanolamine (1)
1,2-dilinoleoylglycerol (1)
1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (1)
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-n,n-dimethyl (1)
1,2-dioleoyl-sn-glycerol (1)
1,2-dipalmitoleoyl-sn-glycero-3-phosphocholine (1)
1,2-dipentadecanoyl-sn-glycero-3-phosphocholine (1)
1,6-anhydro-beta-d-glucose (1)
1-(1z-hexadecenyl)-sn-glycero-3-phosphocholine (1)
1-(1z-octadecenyl)-2-(4z,7z,10z,13z,16z,19z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine (1)
1-(1z-octadecenyl)-sn-glycero-3-phosphocholine (1)
1-aminocyclopropanecarboxylic acid (1)
1-behenoyl-2-hydroxy-sn-glycero-3-phosphocholine (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Integrated metabolomics and network pharmacology investigation of cardioprotective effects of myricetin after 1-week high-intensity exercise

Cardiovascular adverse effects caused by high-intensity exercise (HIE) have become a public health problem of widespread concern. As a phytochemical with potential therapeutic effects, the therapeutic effect and metabolic regulation mechanism of myricetin have rarely been studied. In this study, ...

2023-03-06 | MTBLS5608 | MetaboLights

A DIA-based deep proteome profiling of Pseudomonas aeruginosa PAO1 reference strain under different growth conditions

We used the data-independent acquisition (DIA)-based quantitative proteomics to profile the abundance dynamics of proteins across different growth stages in P. aeruginosa PAO1 reference strain. Extensive modulations of protein expression levels were found in planktonic culture of PAO1 bacteria acros...

ORGANISM(S): Pseudomonas Aeruginosa Pao1

2023-04-06 | PXD038460 |

the proteomics of IGFBP6 in endothelial cells (HUVECs)

To unravel the direct mechanism of the anti-inflammatory effects of IGFBP6 in ECs, we analysed HUVECs treated with either adenovirus-Flag-IGFBP6 (Ad-IGFBP6) or control adenovirus (Ad-NC). We precipitated IGFBP6 from overexpressed ECs followed by mass spectrometry.

ORGANISM(S): Homo Sapiens

2024-05-13 | PXD052204 |

Previous page
1 / 1
You're on page 1
Next page